Table 2.

Age-standardized characteristics of 1,455 men with clinically localized prostate cancer, by vigorous activity, usual walking pace, and overall

Vigorous activity (h/wk)Walking pace (mph)Total; mean (SD) or n (%)
0≥3Ptrenda< 2≥3Ptrenda
No. of participants7221892115021,264
Age at diagnosis, mean (SD), y65 (8)64 (8)0.00769 (7)62 (8)<0.00165 (8)
BMI, kg/m2, %b
 <252439<0.0012235<0.001379 (27)
 25–29.952500.8845530.48750 (53)
 ≥302411<0.0013213<0.001283 (20)
Current smokers, %740.05940.0290 (6)
PSA at diagnosis ≥10 ng/mL, %16120.0923130.03214 (15)
Clinical stage, %b
 T156490.3652570.31801 (55)
 T244510.3648430.31654 (45)
Biopsy Gleason sum, %b
 2–674680.0273690.351,034 (71)
 720280.00420250.28347 (24)
 8–10640.32760.9074 (5)
Primary treatment, %b
 Radical prostatectomy62640.4254670.01922 (63)
 Radiation therapy24240.9729200.04351 (24)
 Hormonal therapy560.34850.23110 (8)
 Other/watchful waiting950.04980.6972 (5)
  • aCalculated by using the median of each category as a continuous term.

  • bPercentages may not add to 100% due to rounding.